InterventionsHuman trial
Efficacy and Safety of HDG1901 vs. Ozempic in Patients with Type 2 Diabetes (T2D)—A Randomized, Open-Label, Bioequivalence Phase 3 Trial
ADA Scientific Sessions 2025 Abstract
The paper
Lixin Guo, Shuguang Pang, Zhifeng Cheng, Junying Xu
Show 8 more authors
Junhua Song, Hongwei Ling, Xiaoxia Shi, Lili Zhang, Xin Wang, Hong Tao Gao, Lijun Shen, Liping Zhong,Beijing
ADA Scientific Sessions 2025 Abstract · 13 Jun 2025
Presented at ADA Scientific Sessions 2025 · Poster 839-P